Mannion L, Watson V, Mullassery V, Nair R, Charlton T, Northover M, Enting D, Van Hemelrijck M, Khan MS, Thurairaja R, Amery S, Chatterton K, Smith K, Hughes S. Treatment preferences of patients with muscle invasive bladder cancer: a discrete choice experiment. BJUI Compass. 2024 Oct 11;5(11):1059-68. doi: 10.1002/bco2.443
Arnaud F, Spreadborough P, Mehalick M, Goforth C. Emulsion effect on the measurement of standard laboratory blood products. Clin Lab. 2020 Nov 1;66(11). doi: 10.7754/Clin.Lab.2020.191232. doi: 10.7754/Clin.Lab.2020.191232
Raspa M, Sacco P, Candrilli SD, Bishop E, Petrillo J. Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist-utility index. J Intellect Disabil Res. 2016 Sep;60(9):844-55. doi: 10.1111/jir.12264